Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2016.06.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mp47-02 Sexual Function After Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer: Results of the Prospective, Randomized Phase 3 Hypro Trial

Journal of Urology
Urology
2016English

Recommendations for Hypofractionated Whole-Breast Irradiation

Revista da Associacao Medica Brasileira
Medicine
2018English

Hypofractionated Radiation Therapy Versus Conventionally Fractionated Radiation Therapy for Early-Stage Breast Cancer: How Do We Choose?

Future Oncology
MedicineCancer ResearchOncology
2015English

Hypofractionated SBRT Versus Conventionally Fractionated EBRT for Prostate Cancer: Comparison of PSA Slope and Nadir

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Comparison of Radiation Dermatitis Between Hypofractionated and Conventionally Fractionated Postoperative Radiotherapy: Objective, Longitudinal Assessment of Skin Color

Scientific Reports
Multidisciplinary
2018English

Intraoperative Radiation Therapy Versus Hypofractionated Whole Breast Irradiation in T1N0, ER Positive Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Hypofractionated Whole Breast Irradiation in Women Less Than 50 Years Old Treated on Prospective Protocols: A Report on Long-Term Cosmesis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Pmu116 - Patient-Reported Outcomes in a Pilot Randomized Trial of Genome Sequencing

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Randomized Trial of Tofacitinib in Active Ulcerative Colitis: Analysis of Efficacy Based on Patient-Reported Outcomes

BMC Gastroenterology
MedicineGastroenterology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy